1998 Lancet case series alleged an MMR–autism link (later fully retracted)
Small, uncontrolled case series that sparked public concern; The Lancet formally retracted it for serious flaws and misconduct.
All topics4 peer-reviewed studies for, 10 against
High-quality epidemiologic evidence does not support the claim that vaccines cause autism. Multiple large cohort studies across different countries and study designs consistently find no association between MMR vaccination and autism diagnosis. These include landmark population-based work in the early 2000s and later nationwide analyses with improved data linkages and subgroup checks, which still show no increased risk. Importantly, studies examining higher-risk children (e.g., those with an older sibling with autism) likewise find no elevated autism rates among vaccinated children, undermining the idea that vaccines “trigger” autism in susceptible groups. While anecdotes and temporally coincident timing (vaccinations occurring around the age when autism symptoms become noticeable) can create a misleading impression of causation, the best-controlled evidence comparing vaccinated versus unvaccinated populations does not show an increase in autism attributable to vaccines. The weight of evidence therefore strongly favors the conclusion that vaccines—including MMR—do not cause autism.
Ranked by citation count.
Small, uncontrolled case series that sparked public concern; The Lancet formally retracted it for serious flaws and misconduct.
Large population-based cohort study found no association between MMR vaccination and autism risk.
Small, uncontrolled case series that sparked public concern; The Lancet formally retracted it for serious flaws and misconduct.
Institute of Medicine reviewed the evidence and found no causal association; hypothesis rejected.
Subsequent investigations and reviews failed to validate a reproducible pathophysiologic mechanism from MMR to autism.
Study of 47,155 children enrolled in Florida Medicaid (1999-2011) examining association between vaccination and neurodevelopmental disorders (autism, ADHD, epilepsy, learning disorders). Found vaccinated children had significantly higher odds of autism (2.70x) and other NDDs, with dose-response relationship and increased risk when combined with preterm birth.
Large population-based cohort study found no association between MMR vaccination and autism risk.
Retrospective cohort analysis found MMR vaccination was not associated with increased autism risk, including among higher-risk children with autistic siblings.
Updated nationwide cohort again shows MMR does not increase autism risk across subgroups/time windows.
Nationwide cohort study found no increased autism risk after MMR vaccination and no evidence of increased risk in susceptible subgroups.
Nationwide cohort provides strong evidence against an MMR–autism link.
A landmark Danish cohort study of 1.2 million children born 1997-2018 found no association between cumulative aluminum exposure from vaccines and autism or 49 other chronic conditions. Adjusted hazard ratios for neurodevelopmental disorders were 0.93 (95% CI: 0.90-0.97), indicating no increased risk with higher aluminum exposure.
A 2025 peer-reviewed literature review examining the relationship between vaccines and autism spectrum disorder across multiple studies and countries. The findings consistently show no causal link between childhood vaccinations (including MMR and thimerosal-containing vaccines) and autism development.
A 2025 PLOS Biology editorial by the journal's staff editors examines the evidence that vaccines are safe and do not cause autism, emphasizing that millions of lives have been saved by vaccines and that global public health cannot be compromised by disinformation campaigns.
A multi-center prospective observational study funded by the NIH that evaluated 434 children aged 18-30 months found no association between maternal mRNA COVID-19 vaccination during or before pregnancy and autism or other neurodevelopmental problems. This large study, conducted through an NIH clinical trials network, provides additional evidence supporting vaccine safety during pregnancy.
WHO systematic review of 31 primary studies (2010-2025) finds most methodologically rigorous studies do not support a causal association between vaccines, including thiomersal-containing vaccines, and autism spectrum disorder. Five meta-analyses included in the review also found no evidence supporting a causal relationship.
Multiple large population-based and nationwide cohort studies, including updated Danish analyses, found no increased autism risk after MMR vaccination. This held across subgroups and time windows.
The Institute of Medicine reviewed the thimerosal hypothesis and found no causal association. A WHO review of studies from 2010 to 2025 also found that the most rigorous research does not support a link between thiomersal-containing vaccines and autism.
Yes. The 1998 Lancet case series that alleged an MMR–autism link was small and uncontrolled, and The Lancet formally retracted it for serious flaws and misconduct.
Childhood vaccinations happen around the age when autism symptoms often become noticeable, so the timing can create a misleading impression of cause and effect. Anecdotes and early claims that were later retracted or not confirmed also shaped public concern.